A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia

NCT04016636 · clinicaltrials.gov ↗

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

CLL

Interventions

OTHER: Standard of Care

Sponsor

Mela Osorio Maria Jose

Collaborators

[object Object]